| Controlling CV risk in CKD patients - Irish Medical Times |
|
|
Irish Medical Times Prof Baigent is the Principal Investigator in the Study of Heart and Renal Protection (SHARP). “In SHARP, we wanted to achieve a large reduction in LDL cholesterol in patients with CKD,” he told IMT. “We also knew that giving a large dose of a statin |